Delivery Order SPE2DB22D3501-SPE2DB25FVD60

Award Date 4/3/25
Potential Completion Date 4/4/25
Potential Value $12K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order valued at $2,497.17 with a firm fixed-price pricing type. It is for the supply of the drug WEGOVY 0.5 MG/0.5 ML PEN 0.5ML, with an ultimate completion date of January 16, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $15,850.19, is a delivery order for the supply of the medication WEGOVY 0.25 MG/0.5 ML PEN 0.5ML. The contract has an ultimate completion date of April 15, 2025 and is a firm fixed-price contract. Amerisourcebergen Drug Corp is the prime contractor, and there is no set-aside designation for this...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,517.04 firm fixed-price delivery order is for the pharmaceutical product WEGOVY 1 MG/0.5 ML PEN 0.5ML, with a completion date of July 10, 2025. The contract is not set aside and represents an open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC)...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,638.00, is a delivery order to provide the drug WEGOVY 0.25 MG/0.5 ML PEN 0.5ML. The contract has a firm fixed price pricing type and an ultimate completion date of December 18, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $9,768.89 firm-fixed-price delivery order is for the drug WEGOVY 0.5 MG/0.5 ML PEN 0.5ML, with a completion date of October 17, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
This federal contract award, valued at $1,722.42, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the medication WEGOVY 0.5 MG/0.5 ML PEN 0.5ML, with an ultimate completion date of April 23, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract has an award value of $12,966.46 and is for the delivery of the drug WEGOVY 0.5 MG/0.5 ML PEN 0.5ML. The contract is a Firm Fixed Price Delivery Order and has an ultimate completion date of March 12, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
This federal contract award, valued at $3,501.44, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of the drug WEGOVY 0.5 MG/0.5 ML PEN 0.5ML. This is a firm-fixed-price delivery order contract with a completion date of February 18, 2025. The contract is not associated with a set-aside program. Amerisourcebergen holds a significant Indefinite Delivery Contract...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,500.59 firm fixed-price delivery order is for the pharmaceutical product WEGOVY 0.5 MG/0.5 ML PEN 0.5ML. The contract has an ultimate completion date of December 17, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a Delivery Order valued at $2,374.92 for the supply of the drug WEGOVY 0.25 MG/0.5 ML PEN 0.5ML. The contract has an ultimate completion date of November 4, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
  • SPE2DB22D3501
    Indefinite Delivery Contract
  • SPE2DB22D3501-SPE2DB25FVD60
    Delivery Order

This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $12,421.32, is a delivery order for the drug WEGOVY 1 MG/0.5 ML PEN 0.5ML. The contract has an ultimate completion date of April 4, 2025 and is a firm fixed price contract. Amerisourcebergen Drug Corp is the prime contractor, and the contract is not designated as a set-aside. This award is part of Amerisourcebergen's broader work with the DLA, including a $999,999,999 Indefinite Delivery Contract (IDC) to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also holds a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000, for similar medical products and prescription drugs.

Generated 7/3/25, 2:57 PM